Clofazimine: A potential therapeutic option for severe COVID-19
Med Hypotheses
.
2021 May:150:110535.
doi: 10.1016/j.mehy.2021.110535.
Epub 2021 Feb 13.
Author
Areej Mohamed Ateya
1
Affiliation
1
Department of Clinical Pharmacy, Faculty of Pharmacy, Ain Shams University, Cairo, Egypt; Institut für Klinische Pharmakologie und Toxikologie, Charité-Universitätsmedizin, Berlin, Germany. Electronic address: areeg.mohamed@pharma.asu.edu.eg.
PMID:
33735762
PMCID:
PMC7880843
DOI:
10.1016/j.mehy.2021.110535
No abstract available
Publication types
Letter
MeSH terms
COVID-19 Drug Treatment*
Clofazimine* / therapeutic use
Humans
Substances
Clofazimine